#Endpoint

Darian Moody

djm_

I've been following @replicache for a few months now and it's the real deal. Congrats to the team on the launch! Why is it so exciting for the future of

Jason Pogue

jpogue1

I promise that if #hydroxychloroquine was an effective therapy for #covid19 we would tell you. Many of us (myself definitely included) were hopeful that it would be at the onset

Jordan Kharofa

kharofaJ

Short #tweetorial on issues related to toxicity in oncology trials. How do we conclude Tx A is more/less toxic than Tx B? Room for improvement when you look at how

Matthew Robbins

matthewrdev

The #covidsafe app is now available in Australia However, it's a shame that they have decided not to release the source code for full transparency.Luckily, I'm a curious chap and

Pramesh CS

cspramesh

The preprints of the #SOLIDARITY trial are out on MedRxiv. While many may lament that all four drugs tested did not show benefit, this is a remarkable trial for many

Les " Get Healthcare Workers PPE" Witherspoon

naturoheretic

@AANP put out a press release calling for the use of Vitamin C ]in what they variously describe as “moderate to severe cases of COVID-19” & “high risk and hospitalized

Holly Tipper

HollyTipper

Welcome to my Twitter presentation for #WallingfordECRTweets ! I’m Holly, a 4th-year @ExeterMed PhD student in @CEH_ecotox group @UK_CEH. I’m researching the effects of pollution on antimicrobial resistance in bacteria

Utibe R. Essien, MD MPH

UREssien

Inpatient Lesson of the Day 7:I remember the findings from this 2018 @NEJM study that aspirin bleeding risk but didn't CVD risk in the elderly.What I didn't remember

Emrysstanton

Emrysstanton1

Polkadot parachains full of promise, but lack of launch date raises concernThe parachain slot auctions are the next big milestone due on the Polkadot roadmap. So, what can we expect?

Robert Saunders

redhistorian

Universities should indeed offer "value for money" - but how do we measure the value of education? Every test that comes from government is crassly econometric. We need to recapture

Prof Darrel Francis ☺ Mk CardioFellows Great Again

ProfDFrancis

Should we do PCI in patients with stable coronary artery disease? Young Guillaume Marquis-Gravel took on this topic at a recent meeting of #CVCTForum. He brought together a wide range

Carlos Osweda

COsweda

ThreadAnother great video by @DaisyCousensIt brings up several crucial points.https://www.youtube.com/watch?v=PpBxmoLqz6o @realDonaldTrump understands that there's nobody more devoted than a convert.When Democrats criticize @kayleighmce

Aisha Shaikh

aishaikh

Effect of Finerenone on CKD outcomes in T2DMFinerenone decreased risk of CKD progression by 18%Finerenone decreased CV morbidity & mortality by 14%Published in @NEJM today https://www.nejm.org/doi/full/10.1056/NEJMoa2025845?query=RP@ASN

Ed

Rx_Ed

What is Remdesivir?This is a thread on the pharmacology of the drug & its hypothesized mechanism of action against #coronavirus #COVID19. I’ll also mention some of the anticipated side effects/toxicity,

Gummi Bear

gummibear737

Let’s take a close look at how HCQ science is being done.This study was published by @boulware_dr in the NEJM in early juneIn a randomized trial for post-exposure, they concluded

Zain Chagla

zchagla

Let's review the history of Remdesivir1) Jan-Feb - COVID hits the world - remdesivir is an interesting compound that needs a home - gilead releases drug to a small number